Ep. 57 Venture Philanthropy, Cancer Research, And The Fight Against Osteosarcoma with Paul Romnes

What happens when cutting-edge science, mission-driven leadership, and nonprofit investment come together to fight one of the world’s most devastating cancers? In this episode of Money to Give, Rick Peck sits down with Paul Romnes to explore the groundbreaking work being done at OS Therapies to combat osteosarcoma — a rare and aggressive bone cancer that affects both children and dogs. Paul shares how his company is developing an innovative immunotherapy designed to activate the body’s own immune system to seek out and destroy lingering cancer cells, potentially offering the first major advancement in osteosarcoma treatment in more than 40 years.Throughout the conversation, Paul also explains the growing role of venture philanthropy and how nonprofit organizations are investing directly into promising research and commercialization efforts to accelerate life-saving therapies. From “bench to bedside” innovation and clinical trials to the emotional realities of pediatric cancer research, this episode highlights how collaboration between science, nonprofits, and mission-focused leadership can create real hope for patients and families facing unimaginable challenges. Whether you are interested in philanthropy, healthcare innovation, biotech investing, or the future of cancer treatment, this episode offers an inspiring and eye-opening look at the power of purpose-driven innovation.Contact Rick Peck:Website: https://www.thephilanthropyguy.comEmail: [email protected] A call: Rick Peck's CalendarSign Up For Charitable Giving Newsletter: Charitable Giving NewsletterLinkedIn: Richard PeckContact Paul Romness:Website: ostherapies.comStock Symbol: OSTX (NYSE American)PBS Feature Film: www.pbs.org/show/shelter-me